Oculogenex

Oculogenex

Biotechnology, 2250 W Whittier BLVD, La Habra, California, 90631, United States, 1-10 Employees

oculogenex.com

  • facebook
  • LinkedIn

phone no Phone Number: 56**********

Who is OCULOGENEX

Oculogenex is a biopharmaceutical company founded and directed by an ophthalmologist retinal surgeon with patients in mind. It was founded out of passion and frustration shared with patie...

Read More

map
  • 2250 W Whittier BLVD, La Habra, California, 90631, United States Headquarters: 2250 W Whittier BLVD, La Habra, California, 90631, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OCULOGENEX

Oculogenex Org Chart and Mapping

Employees

Ram Ramkumar

Chief Operating Officer

Zhongyang Lu

Senior Scientist, Laboratory Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Oculogenex

Answer: Oculogenex's headquarters are located at 2250 W Whittier BLVD, La Habra, California, 90631, United States

Answer: Oculogenex's phone number is 56**********

Answer: Oculogenex's official website is https://oculogenex.com

Answer: Oculogenex's revenue is Under $1 Million

Answer: Oculogenex's SIC: 2836

Answer: Oculogenex's NAICS: 325414

Answer: Oculogenex has 1-10 employees

Answer: Oculogenex is in Biotechnology

Answer: Oculogenex contact info: Phone number: 56********** Website: https://oculogenex.com

Answer: Oculogenex is a biopharmaceutical company founded and directed by an ophthalmologist retinal surgeon with patients in mind. It was founded out of passion and frustration shared with patients losing vision due to lack of therapeutic options. We have professional and scientific experience with retinal diseases, genetic variations in retinal and optic nerve diseases. We have built a team of experts in animal models of macular degeneration, antioxidant therapies for macular degeneration, medical and surgical treatments of retinal diseases and drug delivery methods. This specialized team has been built to utilize genetic engineering technology to improve vision for patients with degenerative eye diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access